Atıf Formatları
Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. UYGUR Et Al. , "Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]," Annual Congress of the European Association of Nuclear Medicine 2023 , Vienna, Austria, 2023

UYGUR, E. Et Al. 2023. Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]. Annual Congress of the European Association of Nuclear Medicine 2023 , (Vienna, Austria).

UYGUR, E., SEZGİN ARIKBAŞI, C., YILDIZ AKDAĞ, B., ÖZBEY, T., PARLAK, Y., KARATAY, K. B., ... GÜMÜŞER, F. G.(2023). Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I] . Annual Congress of the European Association of Nuclear Medicine 2023, Vienna, Austria

UYGUR, EMRE Et Al. "Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]," Annual Congress of the European Association of Nuclear Medicine 2023, Vienna, Austria, 2023

UYGUR, EMRE Et Al. "Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]." Annual Congress of the European Association of Nuclear Medicine 2023 , Vienna, Austria, 2023

UYGUR, E. Et Al. (2023) . "Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]." Annual Congress of the European Association of Nuclear Medicine 2023 , Vienna, Austria.

@conferencepaper{conferencepaper, author={EMRE UYGUR Et Al. }, title={Investigation of the Radiolabelling Potential of the Aurora A Kinase Inhibitor Alisertib with Iodine-123 [123I]}, congress name={Annual Congress of the European Association of Nuclear Medicine 2023}, city={Vienna}, country={Austria}, year={2023}}